Ipamorelin Peptide
Ipamorelin Peptide
Ipamorelin is a selective pentapeptide growth hormone secretagogue that stimulates endogenous GH release by activating the ghrelin receptor (GHSR-1a) without significantly elevating cortisol, prolactin, or ACTH. It is studied for its potential to support muscle anabolism, metabolic optimization, and recovery in research protocols focused on hormonal balance and body composition.
Couldn't load pickup availability
Share

What is Ipamorelin?
Ipamorelin is a synthetic pentapeptide and highly selective growth hormone secretagogue that acts primarily through the growth hormone secretagogue receptor (GHS-R1a), the same receptor involved in the actions of the endogenous hormone ghrelin. Rather than supplying growth hormone directly, Ipamorelin stimulates the pituitary to release the body's own GH. What makes it particularly interesting is its unusually high selectivity: early pharmacological research demonstrated potent GH release with little or no significant stimulation of ACTH, cortisol, prolactin, LH, FSH or TSH at experimentally relevant doses. This selective profile distinguishes Ipamorelin from earlier GHRP compounds and has made it an important research tool for studying the GH axis.
What makes Ipamorelin unique?
Ipamorelin is also notable for producing an episodic GH response. Human pharmacokinetic/pharmacodynamic research found that GH concentrations rose following administration and subsequently declined, consistent with stimulation of the body's normal pulsatile GH system rather than prolonged exposure to exogenous hormone. Through the GH/IGF-1 axis, this signaling is relevant to research involving protein synthesis, connective-tissue turnover, body composition, metabolism, recovery and tissue maintenance. Ipamorelin has also been investigated clinically for gastrointestinal motility, demonstrating that its activity extends beyond the pituitary GH axis, although clinical efficacy for specific therapeutic applications remains under investigation.
Key benefits:
- Stimulates Growth Hormone Release – Potently promotes endogenous GH secretion through GHS-R1a activation.
- Highly Selective GH Secretagogue – Developed specifically to produce GH release with substantially less activity on other pituitary hormones than several earlier GHRPs.
- Supports GH/IGF-1 Axis Research – Provides a useful model for investigating the physiological effects of increased GH signaling and downstream IGF-1 activity.
- Pulsatile GH Signaling – Human research demonstrates an episodic GH response following administration rather than continuous GH exposure.
- Muscle & Protein-Synthesis Research – The GH/IGF-1 pathway is extensively studied for its role in anabolic signaling, protein metabolism and maintenance of lean tissue.
- Recovery & Tissue-Repair Research – GH signaling is involved in connective-tissue turnover and tissue remodeling, making Ipamorelin relevant to experimental recovery research.
- Body-Composition Research – The GH/IGF-1 axis plays an important role in lipid metabolism and body-composition regulation, making selective GH secretagogues an area of metabolic research.
- Connective-Tissue Research – GH and IGF-1 signaling participate in collagen and extracellular-matrix metabolism, supporting investigation of Ipamorelin in tissue-maintenance models.
- Minimal Cortisol Stimulation in Preclinical Studies – Unlike GHRP-2 and GHRP-6, the original comparative research found no significant ACTH/cortisol response from Ipamorelin under the tested conditions.
- No Significant Prolactin Effect in Original Studies – Ipamorelin did not significantly alter prolactin, LH, FSH or TSH in the comparative animal studies.
- Gastrointestinal Research – As a ghrelin-receptor agonist, Ipamorelin has been investigated for gastrointestinal motility, including a randomized clinical study of postoperative ileus.
- Short-Acting Research Compound – Human pharmacokinetic research reported a terminal half-life of approximately two hours, with GH stimulation occurring as a defined physiological response.
- Distinct from Exogenous GH – Ipamorelin stimulates endogenous GH secretion rather than directly administering recombinant growth hormone, making it useful for studying regulation of the body's own GH axis.
- Potentially Broad Research Applications – Its combination of GH-secretagogue activity and receptor selectivity has made Ipamorelin relevant to research into metabolism, tissue maintenance, recovery, aging and endocrine physiology.
What is Ipamorelin?
Ipamorelin is a synthetic pentapeptide and highly selective growth hormone secretagogue that acts primarily through the growth hormone secretagogue receptor (GHS-R1a), the same receptor involved in the actions of the endogenous hormone ghrelin. Rather than supplying growth hormone directly, Ipamorelin stimulates the pituitary to release the body's own GH. What makes it particularly interesting is its unusually high selectivity: early pharmacological research demonstrated potent GH release with little or no significant stimulation of ACTH, cortisol, prolactin, LH, FSH or TSH at experimentally relevant doses. This selective profile distinguishes Ipamorelin from earlier GHRP compounds and has made it an important research tool for studying the GH axis.
What makes Ipamorelin unique?
Ipamorelin is also notable for producing an episodic GH response. Human pharmacokinetic/pharmacodynamic research found that GH concentrations rose following administration and subsequently declined, consistent with stimulation of the body's normal pulsatile GH system rather than prolonged exposure to exogenous hormone. Through the GH/IGF-1 axis, this signaling is relevant to research involving protein synthesis, connective-tissue turnover, body composition, metabolism, recovery and tissue maintenance. Ipamorelin has also been investigated clinically for gastrointestinal motility, demonstrating that its activity extends beyond the pituitary GH axis, although clinical efficacy for specific therapeutic applications remains under investigation.
Key benefits:
- Stimulates Growth Hormone Release – Potently promotes endogenous GH secretion through GHS-R1a activation.
- Highly Selective GH Secretagogue – Developed specifically to produce GH release with substantially less activity on other pituitary hormones than several earlier GHRPs.
- Supports GH/IGF-1 Axis Research – Provides a useful model for investigating the physiological effects of increased GH signaling and downstream IGF-1 activity.
- Pulsatile GH Signaling – Human research demonstrates an episodic GH response following administration rather than continuous GH exposure.
- Muscle & Protein-Synthesis Research – The GH/IGF-1 pathway is extensively studied for its role in anabolic signaling, protein metabolism and maintenance of lean tissue.
- Recovery & Tissue-Repair Research – GH signaling is involved in connective-tissue turnover and tissue remodeling, making Ipamorelin relevant to experimental recovery research.
- Body-Composition Research – The GH/IGF-1 axis plays an important role in lipid metabolism and body-composition regulation, making selective GH secretagogues an area of metabolic research.
- Connective-Tissue Research – GH and IGF-1 signaling participate in collagen and extracellular-matrix metabolism, supporting investigation of Ipamorelin in tissue-maintenance models.
- Minimal Cortisol Stimulation in Preclinical Studies – Unlike GHRP-2 and GHRP-6, the original comparative research found no significant ACTH/cortisol response from Ipamorelin under the tested conditions.
- No Significant Prolactin Effect in Original Studies – Ipamorelin did not significantly alter prolactin, LH, FSH or TSH in the comparative animal studies.
- Gastrointestinal Research – As a ghrelin-receptor agonist, Ipamorelin has been investigated for gastrointestinal motility, including a randomized clinical study of postoperative ileus.
- Short-Acting Research Compound – Human pharmacokinetic research reported a terminal half-life of approximately two hours, with GH stimulation occurring as a defined physiological response.
- Distinct from Exogenous GH – Ipamorelin stimulates endogenous GH secretion rather than directly administering recombinant growth hormone, making it useful for studying regulation of the body's own GH axis.
- Potentially Broad Research Applications – Its combination of GH-secretagogue activity and receptor selectivity has made Ipamorelin relevant to research into metabolism, tissue maintenance, recovery, aging and endocrine physiology.
Pre-Filled Pen
Composition: Each pen contains 10mg Ipamorelin peptide. Other ingredients - bacteriostatic water.
Directions: Inject subcutaneously one to three times per day.
10mg Pre-Filled Pen (SubQ):
Low dose: 0.3 mg = 9 clicks once daily (lasts 33 days)
Moderate dose: 0.3 mg = 9 clicks twice daily (lasts 17 days)
High dose: 0.3 mg = 9 clicks three times daily (lasts 11 days)
Hygiene: Use a new needle daily. Each pen comes with 10 needles, additional needles can be purchased here.
Storage: Keep refrigerated, use within 30 days.
Nasal Spray
Directions: Take two sprays (one in each nostril or under the tongue) two times per day (lasts 12 days).
Storage: Keep refrigerated. Minimize exposure to heat, light and air.
Mixing Instructions:
1) Assemble the syringe and needle; draw up and inject 2ml of sterile saline solution (provided) into the peptide vial (by popping off the plastic cap and injecting the water via the rubber stopper) then allow the powder to dissolve (do not shake).
2) You can gently swirl the peptide vial if needed to make sure that all the powder has dissolved and then draw out all the liquid from the vial with the syringe and inject it into the amber nasal spray bottle (You can turn the vial upside down if needed to get all the liquid out).
3) Add an additional 4ml of sterile saline solution (provided) into the amber nasal spray bottle and tighten the white nasal atomizer. It is now ready to be administered as per dosage directions and stored in the fridge to prevent degradation.
Pre-Filled Pen
Composition: Each pen contains 10mg Ipamorelin peptide. Other ingredients - bacteriostatic water.
Directions: Inject subcutaneously one to three times per day.
10mg Pre-Filled Pen (SubQ):
Low dose: 0.3 mg = 9 clicks once daily (lasts 33 days)
Moderate dose: 0.3 mg = 9 clicks twice daily (lasts 17 days)
High dose: 0.3 mg = 9 clicks three times daily (lasts 11 days)
Hygiene: Use a new needle daily. Each pen comes with 10 needles, additional needles can be purchased here.
Storage: Keep refrigerated, use within 30 days.
Nasal Spray
Directions: Take two sprays (one in each nostril or under the tongue) two times per day (lasts 12 days).
Storage: Keep refrigerated. Minimize exposure to heat, light and air.
Mixing Instructions:
1) Assemble the syringe and needle; draw up and inject 2ml of sterile saline solution (provided) into the peptide vial (by popping off the plastic cap and injecting the water via the rubber stopper) then allow the powder to dissolve (do not shake).
2) You can gently swirl the peptide vial if needed to make sure that all the powder has dissolved and then draw out all the liquid from the vial with the syringe and inject it into the amber nasal spray bottle (You can turn the vial upside down if needed to get all the liquid out).
3) Add an additional 4ml of sterile saline solution (provided) into the amber nasal spray bottle and tighten the white nasal atomizer. It is now ready to be administered as per dosage directions and stored in the fridge to prevent degradation.
At the core of our mission is an unwavering commitment to your health and trust: we employ a rigorous, multi-phase quality control system - backed by accredited certifications and total transparency - to ensure every product we stock is pure, safe, and consistently meets the highest industry standards. From material sourcing through final batch testing, our processes are continually refined to guarantee potency and prevent cross-contamination.
At the core of our mission is an unwavering commitment to your health and trust: we employ a rigorous, multi-phase quality control system - backed by accredited certifications and total transparency - to ensure every product we stock is pure, safe, and consistently meets the highest industry standards. From material sourcing through final batch testing, our processes are continually refined to guarantee potency and prevent cross-contamination.